Composition containing metilpropanotioato S - [2 - (2 - [1 - (2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl] and croscarmellose Sodium tablet; Preparation Process; contains; Kit and use in the treatment and Prevention of cardiovascular disorders.
The present invention relates to a hygroscopic matrix based formulation, a process for the preparation thereof and its use in the treatment of diseases.COMPOSICION FARMACEUTICA QUE CONTIENE 48-55% P/P DE 2-METILPROPANOTIOATO DE S-[2-([[1-(2-ETILBUTIL)-CICLOHEXIL]-CARBONIL]AMINO)FENILO] O DALCETRAPIB, 4-8% P/P DE CROSCARMELOSA SODICA, 32-41% P/P DE POLIMERO INSOLUBLE EN AGUA, 4-5% P/P DE POLIMERO SOLUBLE EN AGUA; PROCESO DE PREPARACION; TABLETA QUE CONTIENE LA COMPOSICION.